The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

6 Jan 2014 07:00

RNS Number : 9249W
PureCircle Limited
06 January 2014
 



PURECIRCLE LIMITED

 

TRADING UPDATE

 

PureCircle (LSE: PURE), the world's largest producer and marketer of high purity stevia ingredients, today provides a trading update in respect of the six month period from 1 July 2013 to 31 December 2013, being the first half of its Financial Year 2014 (1H FY14). The Company's interim results for 1H FY14 will be announced on Wednesday 19 March 2014.

Sales

Sales in 1H FY14 are expected to be $34.7m, an increase of 31% against 1H FY13 ($26.4m* - see note below).

There was growth in sales across all high purity ingredients primarily driven by new innovations in our proprietary Stevia 3.0 TM portfolio of all-natural, no-calorie sweeteners and natural flavor systems. By region, EMEA, Latin America, Asia Pacific and USA all recorded sales growth.

Sales volumes: In 1H FY14 total volumes of high purity stevia sweeteners and natural flavors are expected to increase by 34% against 1H FY13.

 

EBITDA

The benefits of the increase in sales are expected to flow through the Profit and Loss account with the Group moving to positive Operating Profit and EBITDA.

Cash, net debt and funding headroom

The Group ended 1H FY14 with net debt of $86m and cash and facility headroom of $58m. The Group is sufficiently funded for its current expansion plans.

 

Commenting on the 1H FY14 trading, the Group CEO Magomet Malsagov said:  1H FY14 we continued on our path of systematic growth with increase in sales and improvements in profitability.

Our strategy of introducing new and innovative ingredients and solutions to meet identified market needs is continuing to win business for PureCircle and to increase the overall market share for high purity stevia. The success of our innovations is underpinned by our R&D capabilities, uniquely integrated supply chain, global customer service infrastructure and smart partnerships. The recent GRAS Letter of No Objection from the U.S. FDA for Rebaudioside M a new, zero-calorie sweetener from the stevia leaf jointly developed by The Coca-Cola Company and PureCircle is an important milestone for us and is another example of our ongoing commitment to sweetener innovation and our global commitment to offering solutions to help food and beverage industry to develop more reduced, low and no-calorie food and beverage options. We are generating revenues from a wide range of natural sweetener and flavor products and from a wide range of customers directly and through our business partners.

With accelerating roll-outs of food and beverage products using PureCircle's high purity stevia solutions, particularly in the important carbonated soft drink category, the Company is confident of continued sales growth and with it improvements in profitability.

*Note that 1H FY13 sales have been restated to reflect the Company's adoption of the new IFRS accounting policy for Joint Ventures. This has the effect of reducing 1H FY13 sales by $1m

 

 

Enquiries:

PureCircle Limited (www.purecircle.com)

Magomet Malsagov, CEO

+603 2166 2066

William Mitchell, CFO

+44 7974 005 163

RFC Ambrian Ltd (NOMAD)

+61 8 9480 2500

Stephen Allen

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQKADNBBKKQDK
Date   Source Headline
1st Jul 20205:10 pmRNSScheme of Arrangement becomes Effective
30th Jun 20206:00 pmRNSNew External Auditor Appointment
29th Jun 20205:45 pmRNSChanges in the Board Composition
26th Jun 20206:37 pmRNSCourt sanction of the Scheme
18th Jun 20205:47 pmRNSResults of Court Meeting and General Meeting
18th May 20205:45 pmRNSPublication of Scheme Document
7th May 20209:37 amRNSResults of Adjourned 2019 Annual General Meeting
7th May 20207:00 amRNSDispatch Date for Scheme Document
5th May 20202:31 pmRNSPDMR Notification
1st May 20207:00 amRNSBlock Listing Application
29th Apr 20207:00 amRNSNew Banking Facility
28th Apr 20203:22 pmRNSUpdate on Adjourned 2019 Annual General Meeting
20th Apr 20209:04 amRNSForm 8.3 - PureCircle Limited
20th Apr 20208:50 amRNSForm 8.3 - PureCircle Limited
20th Apr 20208:32 amRNSForm 8 (OPD) (PureCircle Limited)
16th Apr 20203:54 pmRNSForm 8.3 - PureCircle Limited
16th Apr 20203:08 pmRNSForm 8 (OPD) (PureCircle Limited)
16th Apr 20202:43 pmRNSForm 8.3 - PureCircle Limited
16th Apr 20202:40 pmRNSForm 8.3 - PureCircle Limited
16th Apr 20202:35 pmRNSForm 8.3 - PureCircle Limited
16th Apr 20202:30 pmRNSForm 8.3 - PureCircle Limited
15th Apr 20207:30 amRNSRestoration PureCircle Limited
9th Apr 20204:52 pmRNSNotice of Adjourned AGM and Annual Report
9th Apr 20202:07 pmRNSOffer for PureCircle Limited
9th Apr 20201:56 pmRNSUnaudited Interim Results and Trading Update
5th Mar 20207:00 amRNSCompany Update
5th Mar 20207:00 amRNSManagement Changes
19th Feb 20207:00 amRNSUpdate on lending facilities
10th Feb 20201:25 pmRNSResults of AGM and Directorate Change
4th Feb 20202:46 pmRNSCFO appointment effective
28th Jan 20203:45 pmRNSManagement Update
14th Jan 20204:42 pmRNSNotice of AGM and Company Update
3rd Jan 20202:00 pmRNSAppointment of CFO
2nd Jan 20207:00 amRNSBlock Listing Six Monthly Return
31st Dec 201912:15 pmRNSBoard Changes
27th Dec 20192:50 pmRNSManagement and Board Committee Changes
12th Dec 20192:40 pmRNSBoard and Management Changes
22nd Nov 20193:38 pmRNSResignation of a Director
20th Nov 20197:52 amRNSCorrection: Appointment of Directors
18th Nov 20193:42 pmRNSAppointment of Directors
14th Nov 20197:40 amRNSCompany Update
12th Nov 20192:52 pmRNSResignation of Director
28th Oct 20197:48 amRNSSuspension of share listing
25th Oct 20195:23 pmRNSPostponement of results and suspension of listing
23rd Oct 20194:35 pmRNSPrice Monitoring Extension
20th Sep 20194:40 pmRNSSecond Price Monitoring Extn
20th Sep 20194:35 pmRNSPrice Monitoring Extension
20th Sep 20194:15 pmRNSPostponement of Results
22nd Aug 20194:35 pmRNSPrice Monitoring Extension
16th Aug 20197:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.